ZALTRAP® (aflibercept) approved in the EU
First and only agent to statistically significantly improve survival in…
5 February 2013 | By Sanofi
First and only agent to statistically significantly improve survival in combination with FOLFIRI chemotherapy after an oxaliplatin regimen...